ATI-052 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Aclaris Therapeutics prices $50m share offering following positive ATI-052 trial results

Fortinet (NASDAQ: FTNT) plunges 21%. Is recurring revenue the problem?

Star Entertainment accepts A$260m money-laundering penalty as WhiteHawk financing faces review

Brinker International (EAT) stock surges 12% as Chili’s delivers 10.1% sales growth and raises FY2027 outlook

Read More

Pharma Industry News

Aclaris Therapeutics prices $50m share offering following positive ATI-052 trial results

Aclaris Therapeutics targets $50M financing after ATI-052 trial success. Explore its cash position, dilution risks and Phase 2b strategy.

bySoujanya Ravi

October 29, 2026

web analytics